Systematic Review
Accepted on 18 Nov 2025
Brain Atrophy in NMOSD and MOGAD: A Meta-Analysis of Volumetric and DTI Biomarkers
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
Type at least 3 characters
1,171 articles
Review
Accepted on 17 Nov 2025
Complement Activation in Immunological Neurological Disorders: Mechanisms and Therapeutic Strategies
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
Original Research
Accepted on 13 Nov 2025
Correlation between fatigue and quality of life among patients with neuromyelitis optica in West China
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
- 187 views
Original Research
Published on 12 Nov 2025
Effect of hyperbaric oxygen therapy on peripheral blood inflammatory markers in patients with neuromyelitis optica spectrum disorder: a retrospective cohort study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1670455
- 801 views
Original Research
Accepted on 11 Nov 2025
Anti-LGI1 Encephalitis: Clinical Presentation, Imaging Profiles, and Prognostic Indicators
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
Original Research
Accepted on 10 Nov 2025
Differential Diagnoses of MS in Clinical Practice: Incidence and Methods for Differential Diagnosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
Original Research
Accepted on 10 Nov 2025
Burden of Comorbidities in People with Multiple Sclerosis: A Population-Based Study in Catalonia
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
Clinical Trial
Published on 06 Nov 2025
Does C1 esterase inhibitor play a role in post COVID-19 neurological symptoms? A randomized, double-blind, placebo-controlled, crossover, proof-of-concept study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1523814
- 691 views
Original Research
Published on 06 Nov 2025
Familial prevalence of psoriasis in patients with multiple sclerosis – results from an Australian survey
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1663031
- 946 views
Original Research
Published on 05 Nov 2025
Effects of eculizumab and rituximab on visual function, motor function and social quality in patients with NMOSD: a comparative study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1698950
- 627 views
Original Research
Accepted on 04 Nov 2025
NEDA-3 using cladribine for multiple sclerosis – effectiveness data from a Norwegian hospital
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
- 242 views
Original Research
Published on 30 Oct 2025
Validating wearable step counts in multiple sclerosis research: a replication study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1709389
- 559 views
Original Research
Published on 29 Oct 2025
A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in Germany
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1674742
- 743 views
Original Research
Published on 27 Oct 2025
Factors influencing health behavior changes in people with early multiple sclerosis: process evaluation of the multicenter randomized controlled POWER@MS1 trial
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1635872
- 1,229 views
Systematic Review
Published on 23 Oct 2025
Effectiveness of respiratory muscle training in adults with multiple sclerosis: a systematic review and meta-analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1665651
- 738 views
Original Research
Published on 23 Oct 2025
The neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with neuromyelitis optica spectrum disorders and multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1598885
- 668 views